ARE THERE ANY DETRIMENTAL EFFECTS OF THE USE OF INHALED LONG-ACTING BETA(2)-AGONISTS IN THE TREATMENT OF ASTHMA

被引：34

作者：

DEVOY, MAB ^{[1
]}

FULLER, RW ^{[1
]}

PALMER, JBD ^{[1
]}

机构：

[1] GLAXO INC,RES INST,RES TRIANGLE PK,NC

来源：

CHEST | 1995年 / 107卷 / 04期

关键词：

ASTHMA; BETA-AGONIST; FORMOTEROL; LONG-ACTING; MORBIDITY; MORTALITY; SAFETY; SALMETEROL;

D O I：

10.1378/chest.107.4.1116

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：1116 / 1124

页数：9

共 64 条

[1]

[Anonymous], 1993, THORAX S, V48, pS1

[2]

ARVIDSSON P, 1991, EUR RESPIR J, V4, P1168

[3]

AYRES JG, 1993, AM REV RESPIR DIS, V147, pA61

[4] EFFECT ON AIRWAY RESPONSIVENESS OF 6 WEEKS TREATMENT WITH SALMETEROL [J].

BEACH, JR ;

YOUNG, CL ;

HARKAWAT, R ;

GARDINER, PV ;

AVERY, AJ ;

COWARD, GA ;

WALTERS, EH ;

HENDRICK, DJ .

PULMONARY PHARMACOLOGY, 1993, 6 (02) :155-157

[5]

BECKER AB, 1993, IMMUNOL ALLERGY PRAC, V15, P213

[6] THE LONG-TERM EFFECTS OF NEDOCROMIL SODIUM AND BECLOMETHASONE DIPROPIONATE ON BRONCHIAL RESPONSIVENESS TO METHACHOLINE IN NONATOPIC ASTHMATIC SUBJECTS [J].

BEL, EH ;

TIMMERS, MC ;

HERMANS, J ;

DIJKMAN, JH ;

STERK, PJ .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (01) :21-28

[7] CHANGES IN METHACHOLINE-INDUCED BRONCHOCONSTRICTION WITH THE LONG-ACTING BETA(2) AGONIST SALMETEROL IN MILD-TO-MODERATE ASTHMATIC-PATIENTS [J].

BOOTH, H ;

FISHWICK, K ;

HARKAWAT, R ;

DEVEREUX, G ;

HENDRICK, DJ ;

WALTERS, EH .

THORAX, 1993, 48 (11) :1121-1124

[8]

BRITTON J, 1991, LANCET, V337, P300, DOI 10.1016/0140-6736(91)90912-9

[9]

BRITTON MG, 1992, EUR RESPIR J, V5, P1062

[10] BRONCHODILATOR TREATMENT IN ASTHMA - STUDY TOO SMALL TO DETECT INCREASE IN DEATHS [J].

BUNNEY, R .

BRITISH MEDICAL JOURNAL, 1993, 306 (6892) :1610-1610

← 1 2 3 4 5 6 7 →